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Abstract: α-Amino-C-phosphinic acids and derivatives are an important group of compounds of
synthetic and medicinal interest and particular attention has been dedicated to their stereoselective
synthesis in recent years. Among these, phosphinic pseudopeptides have acquired pharmacological
importance in influencing physiologic and pathologic processes, primarily acting as inhibitors
for proteolytic enzymes where molecular stereochemistry has proven to be critical. This review
summarizes the latest developments in the asymmetric synthesis of acyclic and phosphacyclic
α-amino-C-phosphinic acids and derivatives, following in the first case an order according to the
strategy used, whereas for cyclic compounds the nitrogen embedding in the heterocyclic core is
considered. In addition selected examples of pharmacological implications of title compounds are
also disclosed.
Keywords: α-amino-C-phosphinic acids; α-amino-C-phosphinates; α-amino acids; stereoselective
synthesis; biological activity
1. Introduction
Optically active α-aminoalkylphosphonic acids 1 are probably the most important analogues of
the α-amino acids 2, obtained by isosteric substitution of the planar and less bulky carboxylic acid
(CO2H) by a tetrahedral phosphonic acid functionality (PO3H2). These classes of compounds are
currently attracting great interest in organic and medicinal chemistry, as well as in agriculture, due to
their important biological and pharmacological properties [1–5]. The great importance of this type
of compounds has prompted organic chemists to report numerous procedures for their racemic or
stereoselective synthesis [6–11]. On the other hand, the optically active α-amino-C-phosphinic acids
3 are also considered as analogues of α-amino acids 2 where now the carboxylic group (CO2H) is
replaced by a tetrahedral and sterically more demanding phosphinic acid functionality (PO2HR′).
As part of peptides, α-amino-C-phosphinic acids 3 are much closer analogues to natural α-amino acids
2 than their α-aminophosphonic counterparts 1, due to their mono acidic character, and the higher
stability of the P-C bond of 3 compared to the P-O bond of 1 (Figure 1) [12].
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phosphonic acids (pKa ~ 0.5–1.5) and both more acidic than the carboxylic acid equivalent (pKa ~ 2.0–
3.0); the former are mono acids and no evidence for the second acidity due to the P-H bond is 
reported, while for phosphonic acids, it is well-known that the second acidity is about 5 pK units 
higher than the first P-OH acidity. Similar to α-amino acids, the aminophosphonic and 
aminophosphinic acids have a zwitterionic form due to the internal hydrogen transfer between the 
P-OH and amino groups [13,14]. In addition, a characteristic feature of tetracoordinated phosphorus 
(III) compounds such as H-phosphonate and H-phosphinate derivatives, is the configurational 
stability of the phosphorus center at room temperature, and their tautomeric equilibria with trivalent 
species that occurs without epimerization at the phosphorus center. This is the basis for synthetic 
applications of these compounds as chiral precursors in several stereospecific transformations [15]. 
Although, different structures of phosphonic and phosphinic groups compared with the carboxylic 
function could a priori disrupt enzyme-ligand interactions, they frequently are recognized by 
enzymes or receptors as inhibitors or false substrates [16,17]. 
 
Figure 1. General structure for α-amino acids (2) and their phosphonic (1) and C-phosphinic (3) analogues. 
Phosphinopeptides containing C-terminal α-aminophosphinic acids have been prepared by 
similar methods to those used with their phosphonic analogues, for example the coupling of  
N-protected amino acids or their active esters with α-aminophosphinates [18], or with free  
α-aminophosphinic acids in organic or aqueous-organic media has been reported [19]. Additionally, 
the synthesis of phosphinopeptides via the Mannich-type condensation of N-Cbz protected 
alkanamides/peptide amides, aldehydes and aryldichlorophosphines, followed by hydrolysis, has 
also been reported [20]. Therefore, the α-amino-C-phosphinic acids are currently attracting interest 
in medicinal chemistry due to their relevance mainly as pseudopeptides, which have acquired 
pharmacological importance in influencing physiologic and pathologic processes, primarily acting as 
inhibitors for proteolytic enzymes. The success of these compounds is based on the resemblance of 
phosphinic acids to the sp3 transition state of the hydrolysis of peptide bonds. Considering that 
lengths of O-P and C-P bonds are significantly longer than the corresponding O-C and C-C bonds, 
the phosphinic fragment might be considered as an extended tetrahedral intermediate and thus can 
be treated similar to the transition state of the hydrolysis (Figure 2) [21]. Moreover, they can act as 
simple analogues of amino acids replacing the carboxylic group by the phosphinic moiety, as non-
hydrolysable phosphate analogues or as chelating agents of metal ions present in the active site of 
the enzymes [22]. A number of excellent reviews on various aspects of their activity in natural systems 
have been published [16,17]. 
Simple pseudopeptides containing α-amino-C-phosphinate moieties replacing the scissile 
peptide bonds, rank among most potent inhibitors of metalloproteinases, where their tumorigenesis 
and invasion-related functions makes these enzymes molecular targets for the development of 
potential anticancer drugs [23]. The role of neutral aminopeptidase in the pathogenesis of 
hypertension provides an opportunity for regulating arterial blood pressure through its inhibition 
with this class of compounds [24]. Furthermore, these pseudopeptides appear to be excellent 
inhibitors to Plasmodium falciparum aminopeptidases, promising targets for a novel treatment of 
malaria [25,26]. α-Amino-C-phosphinic pseudopeptides have also revealed their potential activity in 
the regulation of matrix metalloproteinases (MMPs), whose overexpression or inadequate levels 
leads to pathological states such as osteoarthritis, rheumatoid arthritis and inflammation, but also it 
is associated with tumor growth, invasion and metastasis [27,28]. Additionally, is noteworthy that in 
these derivatives the stereochemistry affects their biological activity, hence the importance of the 
synthesis of these compounds in enantiomerically pure form [29,30]. 
 
Figure 1. General structure for α-amino acids (2) and their phosphonic (1) and C-phosphinic
(3) analogues.
Phosphinic, phosphonic and carboxylic acids differ in several characteristics. The carboxylic
group is planar at carbon while their phosphorus analogues are tetrahedral and considerably larger in
size (the phosphorus atom has a much larger atomic radius than carbon). Phosphinic and phosphonic
acids exist mainly in their tetracoordinate form, and they are considered as mono- and diacids,
respectively. The phosphinic acids (pKa ~1.0) are slightly stronger than the corresponding phosphonic
acids (pKa ~0.5–1.5) and both more acidic than the carboxylic acid equivalent (pKa ~2.0–3.0); the former
are mono acids and no evidence for the second acidity due to the P-H bond is reported, while for
phosphonic acids, it is well-known that the second acidity is about 5 pK units higher than the first P-OH
acidity. Similar to α-amino acids, the aminophosphonic and aminophosphinic acids have a zwitterionic
form due to the internal hydrogen transfer between the P-OH and amino groups [13,14]. In addition,
a characteristic feature of tetracoordinated phosphorus (III) compounds such as H-phosphonate
and H-phosphinate derivatives, is the configurational stability of the phosphorus center at room
temperature, and their tautomeric equilibria with trivalent species that occurs without epimerization
at the phosphorus center. This is the basis for synthetic applications of these compounds as
chiral precursors in several stereospecific transformations [15]. Although, different structures of
phosphonic and phosphinic groups compared with the carboxylic function could a priori disrupt
enzyme-ligand interactions, they frequently are recognized by enzymes or receptors as inhibitors or
false substrates [16,17].
Phosphinopeptides containing C-terminal α-aminophosphinic acids have been prepared by
similar methods to those used with their phosphonic analogues, for example the coupling of
N-protected amino acids or their active esters with α-aminophosphinates [18], or with free
α-aminophosphinic acids in organic or aqueous-organic media has been reported [19]. Additionally,
the synthesis of phosphinopeptides via the Mannich-type condensation of N-Cbz protected
alkanamides/peptide amides, aldehydes and aryldichlorophosphines, followed by hydrolysis, has also
been reported [20]. Therefore, the α-amino-C-phosphinic acids are currently attracting interest
in medicinal chemistry due to their relevance mainly as pseudopeptides, which have acquired
pharmacological importance in influencing physiologic and pathologic processes, primarily acting
as inhibitors for proteolytic enzymes. The success of these compounds is based on the resemblance
of phosphinic acids to the sp3 transition state of the hydrolysis of peptide bonds. Considering that
lengths of O-P and C-P bonds are significantly longer than the corresponding O-C and C-C bonds,
the phosphinic fragment might be considered as an extended tetrahedral intermediate and thus
can be treated similar to the transition state of the hydrolysis (Figure 2) [21]. Moreover, they can
act as simple analogues of amino acids replacing the carboxylic group by the phosphinic moiety,
as non-hydrolysable phosphate analogues or as chelating agents of metal ions present in the active
site of the enzymes [22]. A number of excellent reviews on various aspects of their activity in natural
systems have been published [16,17].
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Figure 2. Similarity between the transition state of peptide hydrolysis and the α-amino-C-phosphinic 
motif. The additional interaction with the metal ion in the metalloproteases active site is included. 
In view of the broad biological applications of the optically active α-amino-C-phosphinic acids 
and their peptidic derivatives, in the last years the development of suitable synthetic methodologies 
for their preparation in optically pure form has been a topic of great interest in several research 
groups [31,32]. In this context, now we would like to report herein a summary of the stereoselective 
synthesis of α-amino-C-phosphinic acids and their derivatives covering the last 20 years. In this 
review article, the compounds have been classified in acyclic and phosphacyclic α-amino-C-
phosphinic derivatives. In the first case an order is established according to the strategy used, in this 
way all procedures can be classified into C-P bond formation using a Pudovik or Kabachnik-Fields 
like reaction, C-H bond formation derived from catalytic asymmetric hydrogenation of  
α,β-dehydroaminophosphinates, resolution methodologies, preparation from chiral α-amino-
phosphonates and also P-C bond formation from chiral α-amino-H-phosphinic derivatives is 
included (Scheme 1). Otherwise, in the second case involving the phosphacyclic derivatives, the 
classification will be based in the presence or lack of the nitrogen atom in the heterocycle. 
 
Scheme 1. General overview of the synthetic strategies leading to α-amino-C-phosphinic acids. 
2. Stereoselective Synthesis of Acyclic α-Amino-C-phosphinic Acids and Derivatives 
2.1. Stereoselective C-P Bond Formation (Addition of Phosphorus Compounds to Imines) 
A strategy widely used for the stereoselective synthesis of α-amino-C-phosphinic acids is the 
addition of a nucleophile HX (X = CN, PO2R, PO2RR′) to a preformed N-substituted chiral imine in 
the presence or absence of a chiral catalyst [33], leading to optically active α-amino carboxylic,  
α-aminophosphonic and α-aminophosphinic acids precursors, respectively. The extent of 
asymmetric induction at the Cα depends on the nature of the substituents (steric or hydrophobic 
interactions) and nucleophile–substrate interactions, which are favored in organocatalytic processes [34]. 
Indeed, the nucleophilic addition of phosphorus compounds (alkyl or aryl phosphinates) to 
imines, a Pudovik-like reaction [35], is an appropriate procedure for the preparation of α-amino-C-
phosphinates. Generally, the high diastereoselective ratio can be explained on the basis of the most 
stable conformation of the Schiff bases, in which the C-H bond of the imine is eclipsed with the  
N–C–H fragment, as would be expected from the 1,3-allylic strain model [36,37], and the nucleophilic 
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tif. iti l i t ti it t t l i i t t ll r teases active site is included.
Simple pseudopeptides containing α-amino-C-phosphinate moieties replacing the scissile peptide
bonds, rank among most potent inhibitors of metalloproteinases, where their tumorigenesis and
invasion-related functions makes these enzymes molecular targets for the development of potential
anticancer drugs [23]. The role of neutral aminopeptidase in the pathogenesis of hypertension
provides an opportunity for regulating arterial blood pressure through its inhibition with this
class of compounds [24]. Furthermore, these pseudopeptides appear to be excellent inhibitors to
Plasmodium falciparum aminopeptidases, promising targets for a novel treatment of malaria [25,26].
α-Amino-C-phosphinic pseudopeptides have also revealed their potential activity in the regulation of
matrix metalloproteinases (MMPs), whose overexpression or inadequate levels leads to pathological
states such as osteoarthritis, rheumatoid arthritis and inflammation, but also it is associated with
tumor growth, invasion and metastasis [27,28]. Additionally, is noteworthy that in these derivatives
the stereochemistry affects their biological activity, hence the importance of the synthesis of these
compounds in enantiomerically pure form [29,30].
In view of the broad biological applications of the optically active α-amino-C-phosphinic acids and
their peptidic derivatives, in the last years the development of suitable synthetic methodologies for their
preparation in optically pure form has been a topic of great interest in several research groups [31,32].
In this context, now we would like to report herein a summary of the stereoselective synthesis of
α-amino-C-phosphinic acids and their derivatives covering the last 20 years. In this review article,
the compounds have been classified in acyclic and phosphacyclic α-amino-C-phosphinic derivatives.
In the first case an order is established according to the strategy used, in this way all procedures
can be classified into C-P bond formation using a Pudovik or Kabachnik-Fields like reaction, C-H
bond formation derived from catalytic asymmetric hydrogenation of α,β-dehydroaminophosphinates,
resolution methodologies, preparation from chiral α-amino-phosphonates and also P-C bond formation
from chiral α-amino-H-phosphinic derivatives is included (Scheme 1). Otherwise, in the second case
involving the phosphacyclic derivatives, the classification will be based in the presence or lack of the
nitrogen atom in the heterocycle.
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2. Stereoselective Synthesis of Acyclic α-Amino-C-phosphinic Acids and Derivatives
2.1. Stereoselective C-P Bond Formation (Addition of Phosphorus Compounds to Imines)
A strategy widely used for the stereoselective synthesis of α-amino-C-phosphinic acids is the
addition of a nucleophile HX (X = CN, PO2R, PO2RR′) to a preformed N-substituted chiral imine
in the presence or absence of a chiral catalyst [33], leading to optically active α-amino carboxylic,
α-aminophosphonic and α-aminophosphinic acids precursors, respectively. The extent of asymmetric
induction at the Cα depends on the nature of the substituents (steric or hydrophobic interactions) and
nucleophile–substrate interactions, which are favored in organocatalytic processes [34].
Indeed, the nucleophilic addition of phosphorus compounds (alkyl or aryl phosphinates)
to imines, a Pudovik-like reaction [35], is an appropriate procedure for the preparation of
α-amino-C-phosphinates. Generally, the high diastereoselective ratio can be explained on the basis of
the most stable conformation of the Schiff bases, in which the C-H bond of the imine is eclipsed with the
N–C–H fragment, as would be expected from the 1,3-allylic strain model [36,37], and the nucleophilic
attack of the alkyl or aryl phosphinate takes place on the less hindered side (in the example below,
R’ is bulkier than the methyl group) (Scheme 2).
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2.1.1. Chiral Imine Compounds 
Petneházy et al. [39] reported the first enantioselective synthesis of α-amino-C-phosphinic acids 
by the addition of phosphinates to chiral imines in the absence of a catalyst. In this regard, the  
(S)-α-methylbenzylamine and (S)-α-methoxymethylbenzylamine derived imines 4a–g were reacted 
with ethyl phenylphosphinate in toluene at 70 °C, to obtain the α-amino-C-phosphinates 5a–g in 
40%–84% yield and moderate diastereoisomeric ratio. The hydrolysis of the phosphinate moiety in 
5a–g using concd. HCl or HBr/AcOH, followed by treatment with propylene oxide and 
hydrogenolysis using Pd/C in MeOH, provided the optically active α-amino-C-phosphinic acids  
6a–d in 20%–60% yield and with an enantiomeric ratio of good to excellent (Scheme 4). 
 
Scheme 4. First enantioselective synthesis of α-amino-C-phosphinic acids 6a–d. 
Scheme 2. Model to explain the high diastereoselectivity in the nucleophilic addition to chiral
imine compounds.
Contrary to the phosphonate synthesis, the addition of H-phosphinates to imines results in
the generation of two new stereogenic centers due to the attack of the chiral phosphinates at the
prochiral C=N bond [38]; however, the phosphorus chirality is lost during the hydrolysis through the
delocalization of P=O bond due to d-p pi bond (Scheme 3) [28].
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2.1.1. Chiral Imine Compounds
Petneházy et al. [39] reported t e first e antioselective synthesis of α-amino-C-phosphinic
acids by t e addition of phosphinates to chiral imines in the absence of a catalyst. In this regar ,
the (S)-α-met ylbenzylami e and (S)-α-methoxymethylbenzylamine derived imines 4a–g were reacted
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with ethyl phenylphosphinate in toluene at 70 ◦C, to obtain the α-amino-C-phosphinates 5a–g in
40%–84% yield and moderate diastereoisomeric ratio. The hydrolysis of the phosphinate moiety in
5a–g using concd. HCl or HBr/AcOH, followed by treatment with propylene oxide and hydrogenolysis
using Pd/C in MeOH, provided the optically active α-amino-C-phosphinic acids 6a–d in 20%–60%
yield and with an enantiomeric ratio of good to excellent (Scheme 4).
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Recently, Zhao et al. [40] described the synthesis of a P-chiral compound, whose RP
chirality, was fully confirmed by X-ray analysis. In this context, the hydrophosphinylation of the
N-(R)-α-methylbenzyl Schiff base (R)-4g with the (RP)-O-(−)-menthyl phenylphosphinate at 80 ◦C,
gave after crystallization the optically pure O-menthyl phosphinate (R,S,R)-7 (Scheme 5).
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The reaction of (R,S)-9a with aqueous AgNO3/HNO3 in methanol at 50 °C, produced the  
α-amino-C-phosphinate 10a in 63% yield and with 78:22 diastereoisomeric ratio, which by treatment 
with HBr/AcOH, afforded the enantiomerically pure (S)-α-aminobenzyl phenylphosphinic acid 6d 
(Scheme 8) [41]. 
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Sche e 5. Synthesis of the P-chiral O- enthyl phosphinate (R,S,R)-7.
Rossi et al. [41] carried out the nucleophilic addition of the racemic ethyl phenylphosphinate onto
the chiral imines 8a,b in chloroform at 60–70 ◦C, to obtain the α-amino-C-phosphinates 9a,b in 96%
and 80% yield, respectively, and good diastereoselectivities (Scheme 6).
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Sche e 6. ucleophilic addition of ethyl phenylphosphinate onto the chiral i ines 8a,b.
The (S)-configuratio Cα of the major diastereoisomers 9a resulted from the preferred addition
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according to the 1,3-allylic strain model [37], as shown in the Scheme 7 [41].
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Scheme 7. Preferential addition of ethylphenylphosphinate onto the si face of the imine 8a.
The reaction of (R,S)-9a with aqueous AgNO3/HNO3 in methanol at 50 ◦C, produced the
α-amino-C-phosphinate 10a in 63% yield and with 78:22 diastereoisomeric ratio, which by treatment
with HBr/AcOH, afforded the enantiomerically pure (S)-α-aminobenzyl phenylphosphinic acid 6d
(Scheme 8) [41].
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Carbohydrate derivatives are efficient auxiliaries in many stereoselective chiral syntheses [42–44].
For example, Chen et al. [45] achieved the nucleophilic addition of ethyl phenylphosphinate
to N-galactosylaldimines 11a–g in the presence of catalytic amounts of SnCl4 in THF at room
temperature to obtain the N-galactosyl α-aminoalkyl-C-phosphinates 12a–g in good yield and
moderate diastereoselectivity (Scheme 9). Diastereoisomerically pure compounds 12a–c,e,g were
obtained by recrystallization.
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Scheme 9. Nucleophilic addition of ethyl phenylphosphinate to N-galactosylaldimines 11a–g.
The (S)-configuration at the α-carbon of the major diastereoisomers 12a–g can be explained by
the attack of ethyl phenylphosphinate from si face of (E)-imines 11a–g. The imine-SnCl4 complex and
simultaneous chelation with the auxiliary’s pivaloyl group inhibits free rotation along the N-anomeric
carbon bond. According to this rationalization, the attack of the phosphinate in its PIII phosphonous
tautomeric form proceeds from the back face of the imine 11a–g, as shown in Scheme 10 [45].
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Sche e 10. Plausible reaction echanis for the addition of ethyl phenylphosphinate to 11a–g.
With the aim to assign the configuration, the reaction of N-galactosyl α-aminoalkyl-C-
phosphinates 12a–g with 1 M HCl/MeOH at room temperature produced the α-amino-C-phosphinate
hydrochlorides 13a–g in 78%–95% yield, which by hydrolysis with 1.5 M HCl under reflux followed
by treatment with propylene oxide in ethanol at reflux, afforded the α-amino-C-phosphinic acids 6d
and 14a–f in 82%–93% yield and with 73%–97% enantiomeric excess (Scheme 11) [45].Molecules 2016, 21, 1141 7 of 29 
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hydrogen bonding, Tan et al. [49] carried out the hydrophosphinylation reaction of the N-tosyl imines 
18a–g with arylphosphinates and alkylphosphinates in the presence of catalytic amounts of the 
guanidinium salt 19·HBArF4 in a CH2Cl2:toluene mixture and K2CO3 as a base at −40 °C, obtaining 
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Readily available enantiopure sulfinylimines also constitute valuable molecules in asymmetric
synthesis [46]. Indeed, Petneházy et al. [47] reported the synthesis of optically enriched α-amino-C-
phosphinic acids using ethyl phenylphosphinate and chiral N-sulfinylaldimines. In this context,
the nucleophilic addition of ethyl phenylphosphinate to the chiral imines (S)-15a–c in toluene at
70 ◦C, furnished the α-amino-C-phosphinates (RC,SS)-16a–c in 19%–35% yield, which by simultaneous
removal of the N-sulfinyl auxiliary and hydrolysis of the ethyl phosphinate with concentrated HCl
at reflux, gave the α-amino-C-phosphinic acids (R)-6a,d and (R)-17a in 48%–58% yield and 20%–40%
enantiomeric excesses (Scheme 12).
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2.1.2. Chiral Catalyst
The stereoselective hydrophosphinylation of aldimines under organocatalytic conditions is
emerging as a suitable method for the synthesis of optically active α-amino-C-phosphinates, in this
regard the guanidines and guanidinium salts have shown to be highly efficient catalysts for
enantioselective reactions [48]. For example, following the principle of activation of imines through
hydrogen bonding, Tan et al. [49] carried out the hydrophosphinylation reaction of the N-tosyl
imines 18a–g with arylphosphinates and alkylphosphinates in the presence of catalytic amounts of the
guanidinium salt 19·HBArF4 in a CH2Cl2:toluene mixture and K2CO3 as a base at−40 ◦C, obtaining the
α-amino-C-phosphinates 20a–k in 71%–93% yield and 3:1–16:1 diastereoisomeric ratio, with preference
for the diastereoisomers (RC,SP)-20a–k with 82%–94% enantiomeric excess (Scheme 13).
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2.2. Stereoselective C-P Bond Formation (One-Pot Three-Component Reaction)
2.2.1. Chiral Amino Compounds
Possibly the simplest experimental proposal to prepare optically active α-amino-C-phosphinates
is the “one-pot” three-component reaction, where the reactants are placed all together with or without
solvent and catalyst, which is identical to the Kabachnik-Fields reaction widely studied in the synthesis
of α-aminophosphonates [50–52].
Meng and Xu [19] reported a direct synthetic route for the preparation of phosphinopeptides
containing C-terminal α-aminoalkyl-C-phosphinic acids, valuable peptide mimics. Thus, the “one-pot”
three-component reaction of N-Cbz-aminoalkanamides (S)-21a–c obtained from N-protected amino
acids, with benzaldehyde and phenyldichlorophosphine in dry acetonitrile at 80 ◦C followed by
hydrolysis, produced the phosphinopeptides 22a–c in 65%–75% yield and low degree of asymmetric
induction, obtaining the (S,S)-22a–c diastereoisomers as major products (Scheme 14).
According to the authors, the reaction of the N-Cbz-aminoalkanamide, benzaldehyde and
phenyldichlorophosphine produce the N-acylimine 23b and phenylchlorophosphonous acid, which
attacks to the imine favorably from the si face because the amino acid substituent blocks the
opposite re face. Finally, a proton transfer affords the intermediate aminoalkylphosphinic chloride,
which undergoes hydrolysis gave the (S,S)-phosphinopeptide 22b as major product (Scheme 15) [19].
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Similarly, a series of phosphinodepsipeptides were synthesized via a pseudo-four-component
condensation reaction, in a convergent and atom economic synthetic strategy [53]. In this context,
the “one-pot” reaction of N-Cbz-amino amides derived from amino acids with different aldehydes and
aryldichlorophosphines in dry acetonitrile at 80 ◦C followed by alcoholysis with α-hydroxy esters or
ethanol, produced the phosphinodepsipeptides 24a–k in 50%–66% yield and low diastereo selectivities,
where the (RC*,RP*)-products were assumed as major diastereoisomers (Scheme 16).Molecules 2016, 21, 1141 9 of 29 
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In a similar way, Meng et al. [54] reported the preparation of hybrid sulfonophosphinopeptides
incorporating α-aminoalkyl-C-phosphinic acids. The compounds of interest were synthesized
by reaction of the N-Cbz protected aminoalkanesulfonamides, benzaldehyde and phenyldichloro
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phosphine in dry acetonitrile at 45 ◦C and subsequent hydrolysis at room temperature, obtaining the
sulfonophosphinodipeptides 26a–d in good yield, but low diastereoselectivity. The diastereo isomers
(S,S)-26a–d were assumed as the major products (Scheme 17).
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Additionally, Oehme et al. [57] conducted a comprehensive study on the hydrogenation of
α,β-dehydroaminophosphinates evaluating different chiral rhodium complexes, substrate-catalyst
ratio, temperatures, hydrogen pressures, modified substrates and both organic and aqueous
solvents. Thus, under optimized conditions, they carried out the catalytic hydrogenation
of the α,β-dehydroaminophosphinates 27a–g [56] in the presence of catalytic amounts of
[Rh(cod)(S,S)-bppm]BF4 28 in aqueous micellar media at room temperature and 1 bar H2-pressure,
obtaining the α-amino-C-phosphinates 29a–g in 66%–100% yield and with 53%–97% enantiomeric
excess (Scheme 19).
Furthermore, Darses et al. [58] reported an alternative approach for the synthesis of α-amino-C-
phosphinates through the asymmetric rhodium-catalyzed addition of organoboron derivatives to
α,β-dehydroaminophosphinates. Indeed, the addition of potassium phenyltrifluoroborate to the
α,β-dehydroaminophosphinate 30 [59] in the presence of NaHCO3, [RhCl(CH2CH2)2]2 as catalyst
precursor and (S)-DifluorPhos 31 as chiral ligand in isopropyl alcohol at 90 ◦C, afforded the
diastereoisomeric α-amino-C-phosphinates 32 and 33 in moderate yield and with 94% and 92%
enantiomeric excesses, respectively (Scheme 20).
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2.4. Resolution Methodologies 
The resolution strategies of racemic compounds have also demonstrated its usefulness for the 
preparation of optically enriched α-amino-C-phosphinic acids. For example, Lämmerhofer et al. [60] 
carried out the chiral HPLC separation of N-Cbz phosphinic pseudopeptide esters 34a–d as well as 
their free C-terminal carboxylic derivatives 34e–h using a set of cinchona alkaloid-derived chiral 
anion-exchangers 35,36 (Scheme 21). Semi-preparative scale chromatography supplied single 
enantiomers in 100 mg quantities allowing the biological activity assays. 
In a related work, Lämmerhofer et al. [61] developed a capillary electrochromatography (CEC) 
method for the separation of the stereoisomers of N-Cbz phosphinic pseudodipeptide methyl ester 
37a and 38a and its N-DNP derivative with free C-terminal carboxylic group 37b and 38b, using a 
monolithic silica capillary column modified with a cinchona alkaloid-derived anion-exchange-type 
chiral selector 39 (Scheme 22). This method proved superiority compared to the HPLC separation, 
which was attributed to significantly enhanced plate numbers. 
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2.4. Resolution Methodologies
The resolution strategies of racemic compounds have also demonstrated its usefulness for the
preparation of optically enriched α-amino-C-phosphinic acids. For example, Lämmerhofer et al. [60]
carried out the chiral HPLC separation of N-Cbz phosphinic pseudopeptide esters 34a–d as well
as their free C-terminal carboxylic derivatives 34e–h using a set of cinchona alkaloid-derived
chiral anion-exchangers 35,36 (Scheme 21). Semi-preparative scal chromat graphy supplied single
enantiomers in 100 mg quantities allowing the biological activity assays.Molecules 2016, 21, 1141 11 of 29 
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Mucha, et al. [63] carried out the chiral HPLC separation of all stereoisomers of phosphinic dipeptide 
homophenylalanyl-phenylalanine derivative 40 and 41 on a quinidine carbamate modified silica 
stationary phase 42 (Scheme 23). Significant differences in inhibition of the unprotected derivatives 
43 and 44 show the importance of the molecular stereochemistry in spatial interaction with the 
enzyme active site. 
In another example, Ragulun and Rozhko [64] reported the preparation of the optically pure  
α-aminobenzyl hydroxymethyl phosphinic acid (R)- and (S)-45, where the key step was a biocatalytic 
resolution. Thus, the racemic α-aminobenzyl hydroxymethyl phosphinic acid (±)-45, obtained from 
the hydroxymethyl phosphinic acid, was acylated with phenylacetyl chloride and KOH in water to 
obtain the N-phenylacetyl derivative 46 in 63% yield, which by hydrolysis using penicillin amidase 
(PcAm) as the biocatalyst, afforded the enantiomerically pure (R)-46 in 62% yield and the deacylated 
product (S)-45 in 57% yield. Finally, hydrolysis of compounds (R)-46 with 6 N HCl at reflux followed 
by treatment with propylene oxide, provided the α-amino-C-phosphinic acid (R)-45 in 84% yield 
(Scheme 24). 
Scheme 21. Chiral HPLC separation of N-Cbz phosphinic pseudopeptides 34a–h.
In a related work, Lämmerhofer et al. [61] developed a capillary electrochromatography (CEC)
method for the separation of the stereoisomers of N-Cbz phosphinic pseudodipeptide methyl ester
37a and 38a and its N-DNP derivative with free C-terminal carboxylic group 37b and 38b, using a
monolithic silica capillary column modified with a cinchona alkaloid-derived anion-exchange-type
chiral selector 39 (Scheme 22). This method proved superiority compared to the HPLC separation,
which was attributed to significantly enhanced plate numbers.
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Taking into account that phosphinic dipeptides, although tested as stereoisomeric mixtures,
are considered amongst the most potent inhibitors of bizinc cytosolic leucine aminopeptidase
(LAP) [62], Mucha, et al. [63] carried out the chiral HPLC separation of all stereoisomers of phosphinic
dipeptide homophenylalanyl-phenylalanine derivative 40 and 41 on a quinidine carbamate modified
silica stationary phase 42 (Scheme 23). Significant differences in inhibition of the unprotected
derivatives 43 and 44 show the importance of the molecular stereochemistry in spatial interaction with
the enzyme active site.Molecules 2016, 21, 1141 12 of 29 
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DMF in MeCN, afforded the phosphonomonochloridate (1S,2S)-49, that without additional 
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In another example, Ragulun and Rozhko [64] reported the preparation of the optically pure
α-aminobenzyl hydroxymethyl phosphinic acid (R)- and (S)-45, where the key step was a biocatalytic
resolution. Thus, the racemic α-aminobenzyl hydroxymethyl phosphinic acid (±)-45, obtained from
the hydroxymethyl phosphinic acid, was acylated with phenylacetyl chloride and KOH in water to
obtain the N-phenylacetyl derivative 46 in 63% yield, which by hydrolysis using penicillin amidase
(PcAm) as the biocatalyst, afforded the enantiomerically pure (R)-46 in 62% yield and the deacylated
product (S)-45 in 57% yield. Finally, hydrolysis of compounds (R)-46 with 6 N HCl at reflux followed
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by treatment with propylene oxide, provided the α-amino-C-phosphinic acid (R)-45 in 84% yield
(Scheme 24).
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2.5. Conversion from Chiral α-Aminophosphonates
Undoubtedly, a useful but not as explored strategy for the synthesis of optically enriched
α-amino-C-phosphinic acids is their conversion from the corresponding enantiomerically pure
α-aminophosphonic counterparts [8]. Considering this possibility, Pyun et al. [65,66] carried
out the transformation of chiral phosphonate (1S,2S)-47 into C-phosphinates (1S,2S)-50a–l. Thus,
the reaction of the optically pure diethyl (1S,2S)-1-amino-2-vinylcyclopropanephosphonate 47 [67]
with benzyl chloroformate and NaHCO3 followed by treatment with NaI in pyridine at reflux, gave
the phosphonate monoester (1S,2S)-48 in 88% yield. The reaction of (1S,2S)-48 with oxalyl chloride and
DMF in MeCN, afforded the phosphonomonochloridate (1S,2S)-49, that without additional purification
was reacted with different organolithium or Grignard reagents, to obtain the α-amino-C-phosphinates
(1S,2S)-50a–d in 37%–56% yield, which have been used in the design and synthesis of new enzyme
inhibitors (Scheme 25).
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On the other hand, the reduction of the phosphonomonochloridate (1S,2S)-49 with LiAlH(Ot-Bu)3
in THF at −78 ◦C, produced the H-phosphinate (1S,2S)-51 in 78% yield, which by alkylation either
by activation with chlorotrimethylsilane (TMSCl) and diisopropyl ethylamine (DIPEA) followed by
addition of an alkyl halide (method A), or using NaHMDS and subsequent addition of an alkyl
halide (method B), furnished the P-alkylated α-amino-C-phosphinates (1S,2S)-50e–l in 27%–63% yield
(Scheme 26) [65,66].
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The acyclic C-phosphinate analog 54a showed an IC50 of 6 nM, whereas the carboxylic 56 and 
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Additionally, the reaction of (1S,2S)-50a–l with iodotrimethylsilane in MeCN produced
the simultaneous deprotection of both the Cbz group and the ethyl ester, to obtain the
α-amino-C-phosphinic acids (1S,2S)-52a–l. On the other hand, cleavage of N-Cbz bond in (1S,2S)-50a–l
with TFA-SMe2 [68] gave the α-amino-C-phosphinates (1S,2S)-53a–l. Both, the α-amino-C-phosphinic
acids (1S,2S)-52a–l and C-phosphinates (1S,2S)-53a–l were used in the synthesis of the acyclic 54a–l
and cyclic 55a–l C-phosphinate analogs of BI-2061 [66], respectively, and their inhibition of the HCV
NS3 protease was tested (Scheme 27).
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The acyclic C-phosphinate analog 54a showed an IC50 of 6 nM, where s the carboxylic 56 and
phospho ic 57 derivatives were found to have an IC50 of 3 and 0.9 nM, respectively. The lower
inhibition of the C-phosphinic compared to its phosphonic analog was attributed to the loss of
H-bonding interaction (Figure 3) [66].
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Recently, Hammerschmidt et al. [69] reported the s-BuLi or LiTMP induced phosphonate-
phosphinate rearrangement of N-Boc α-aminophosphonates through deprotonation- metallation at 
the methoxy group. In this context, the treatment of enantiomerically pure N-Boc  
α-aminophosphonate 58 with 2.5 equiv of LiTMP in dry THF at −78 °C followed by acidic workup, 
provided the C-phosphinates (R,SP)-64 and (R,RP)-65 in 12% yield and with 22:78 diastereoisomeric 
ratio, via the metallated phosphonates (RC,SP)-60 and (RC,RP)-61 and the ensuing rearrangement to  
C-phosphinates (RC,SP)-62 and (RC,RP)-63, respectively (Scheme 28). 
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In this context, the chiral α-amino-H-phosphinates have also proved efficiency as P-nucleophiles in 
Michael additions. In this regard, Yiotakis et al. [27,71] reported the synthesis of dehydroalaninyl 
phosphinic dipeptide analogues, which were tested as zinc-metalloproteases MMP-8 inhibitors. For 
this purpose, the optically pure α-amino-H-phosphinic acid (R)-66a [72] was reacted with 
TMSCl/DIPEA in CH2Cl2 followed by addition of tert-butyl 2-(bromomethyl)acrylate, obtaining the 
dehydroalanine derivative (R)-67 in 94% yield, presumably via an allylic rearrangement. Cleavage of 
the O-tert-butyl bond in (R)-67 with trifluoroacetic acid (TFA) and coupling with L-tryptophanyl-
amide, gave the pseudotripeptide (R,S)-68 in 69% yield. Finally, the Michael-type addition of benzyl 
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Figure 3. Carboxylic 56, phosphonic 57 and C-phosphinic 54a nalogs of BI-2061 and activities as
inhibitors of the HCV NS3 protease.
Recently, Hammerschmidt et al. [69] reported the s-BuLi or LiTMP induced phosphonate-
phosphinate rearrangement of N-Boc α-aminophosphonates through deprotonation- metallation at the
methoxy group. In this context, the treatment of enantiomerically pure N-Boc α-aminophosphonate 58
with 2.5 equiv of LiTMP in dry THF at−78 ◦C followed by acidic workup, provided the C-phosphinates
(R,SP)-64 and (R,RP)-65 in 12% yield and with 22:78 diastereoisomeric ratio, via the metallated
phosphonates (RC,SP)-60 and (RC,RP)-61 and the ensuing rearrangement to C-phosphinates (RC,SP)-62
and (RC,RP)-63, respectively (Scheme 28).
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There is a continuously growing interest in phosphorus-carbo bo formation due to the great
applications of organophosphorus com ounds in synthetic organic and bioorganic chemistry [5,70].
In this context, the chiral α-amino-H-phosphinates have also proved efficiency as P-nucleophiles i
Michael additions. In this re ard, Yiotakis et al. [27,71] reported the synthesis of dehydroalaninyl
phosphinic dipeptide analogues, which were tested as zinc-metalloproteases MMP-8 inhibitors. For this
purpose, the optically pure α-amino-H-phosphi ic acid (R)-66a [72] was reacted with TMSCl/DIPEA
in CH2Cl2 followe by addition of tert-but l 2-(bromo ethyl)acrylate, obtaining the dehydroalanine
derivative (R)-67 in 94% yield, presumably via an allylic rearrangement. Cleavage of the O-tert-butyl
bond in (R)-67 with trifluoroacetic acid (TFA) and coupling with L-tryptophanyl- mide, gave the
pseudotripeptide (R,S)-68 in 69% yield. Finally, the Michael-type addition of benzyl thiols to (R,S)-68,
produced the cysteine analogues 69a–c in good yield (Scheme 29).
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On the other hand, McKittrick et al. [73] reported the synthesis of the phosphinic pseudotripeptide
(R,S)-71, which not only inhibits the metalloprotease endothelin converting enzyme (ECE), but also the
angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) with IC50 values <100 nM.
Thus, the hydroxyphosphinyl group in enantiopure Cbz-protected phenylalanine phosphinic analogue
(R)-66a [72] was reacted with diazomethane, followed by treatment with LDA in THF at −78 ◦C and
subsequent addition of the triflate, to afford the P-alkylated α-amino-C-phosphinate (R)-70 in 43%
yield, which was further transformed into pseudotripeptide (R,S)-71 (Scheme 30).
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In a similar way, Roques et al. [77] reported the synthesis of the phosphinic pseudopeptide 
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Scheme 31. Synthesis of phenyl phosphinate derivatives 73a,b and second-order rate constants
[A = k/Ki] of inhibition of chymotrypsin and human neutrophile elastase (HNE).
Additionally, Lloyd et al. [75] synthesized the C-phosphinic acid 75 and tested its effect on
ECE inhibition. In this context, the reaction of α-amino-H-phosphinic acid (R)-66a obtained by
resolution [72], with N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) followed by the Michael
addition to ethyl 2-benzylacrylate and subsequent basic hydrolysis of the ethoxycarbonyl group,
produced the C-phosphinic acid 74. Finally, the reaction of 74 with oxalyl chloride, followed by
coupling with (S)-Trp-OMe and subsequent saponification with LiOH, afforded the phosphinic
pseudopeptide 75 as a 4:1 diastereoisomeric mixture (Scheme 32).
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Roques et al. [76] reported the synthesis of the iodinated tripeptide (R,S,S)-78 analogue of a highly
efficient amin peptidase N inhibitor, as a tool for compl te characterization of the biochemical and
pharmacological properties of this enzyme. The Michael additio of N-Cbz alanine H-phosphinic
analogue (R)-66c obtained by resolution [72], to the m thyl benzylacrylate in th presence of
N,O-bistrimethylsilylacetamide (BSA), followed by alkaline hydrolysis and subsequent c upling
with the L-tyrosine benzyl ester, produced the tripeptide 76 in 57% yiel as a diastereoisomeric mixture,
which by saponification of benzyl ester and Cbz removal under acidic conditions, gave the (R,S,S)-77
diastereoisomer in 47% yield after HPLC separation. Finally, the radioiodination of (R,S,S)-77 was
performed by using Na125I in sodium hydroxide solution and chloramine-T, providing the radiolabeled
compound (R,S,S)-78 (Scheme 33).
In a similar way, Roques et al. [77] reported the synthesis of the hosphinic pseudopepti e
(R,S,S)-81, which proved to be a potent dual inhibitor of the zinc metallopeptidases neprilysin and
aminopeptidase N. For this purpose, the Michael addition of N-Cbz alanine H-phosphinic acid (R)-66c
obtained b res lution [72], to ethyl p-bromobenzylacrylate followed by a Suzuki coupling using
phenylboronic aci and subsequent alkaline hydrolysis of the ethyl ester, gave the C-phosphinic acid
derivative 79 in 75% yield, which by the coupling with (S)-alani e methyl ester afforded the tripeptide
80 in 59% yield. Finally, the saponification of the methyl ester followed by the cleavage of the N-Cbz
bo d with BBr3 and t e semipreparative HPLC purification, provided the enantiomerically pure
phosphinic pseudopeptide (R,S,S)-81 in 92% yield (Scheme 34).
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In a related work, Samios et al. [78] developed an efficient synthetic methodology for the 
preparation of the phosphinic pseudotripeptide known as RXP03, which has been widely studied as 
MMPs inhibitor [79,80]. Initially, reaction of the N-Cbz H-phosphinic acid analogue of phenylalanine 
(R)-66a [72] with bis(trimethylsilyl)amine (HMDS) followed by the addition of ethyl phenylpropyl-
acrylate and subsequent hydrolysis of the ethyl ester group, gave C-phosphinate 82 in 90% yield, 
which by coupling with (S)-TrpNH2, afforded the phosphinic pseudotripeptides (R,S,S)-83 and 
(R,R,S)-84 in 77% yield, which were separated in 99% purity by preferential precipitation in EtOH 
(Scheme 35). This methodology allows the separation of the diastereoisomers based in their solubility 
differences, which was explained by conformational and solvation theoretical studies in terms of their 
intra- and intermolecular structure. 
Similarly, the phosphinic pseudotripeptides (S,S,S)-85 and (S,R,S)-86 were obtained from the 
enantiomeric pure N-Cbz H-phosphinic acid analogue of phenylalanine (S)-66a in 64% yield. As in 
the previous example, each diastereoisomer showed different solubility properties in ethyl ether 
allowing their complete separation (Scheme 36) [78]. 
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In a related work, Samios et al. [78] developed an efficient synthetic methodology for
the preparation of the phosphinic pseudotripeptide known as RXP03, which has been widely
studied as MMPs inhibitor [79,80]. Initially, reaction of the N-Cbz H-phosphinic acid analogue of
phenylalanine (R)-66a [72] with bis(trimethylsilyl)amine (HMDS) followed by the addition of ethyl
phenylpropyl-acrylate and subsequent hydrolysis of the ethyl ester group, gave C-phosphinate 82 in
90% yield, which by coupling with (S)-TrpNH2, afforded the phosphinic pseudotripeptides (R,S,S)-83
and (R,R,S)-84 in 77% yield, which were separated in 99% purity by preferential precipitation in EtOH
(Scheme 35). This methodology allows the separation of the diastereoisomers based in their solubility
differences, which was explained by conformational and solvation theoretical studies in terms of their
intra- and intermolecular structure.
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Considering that phosphinic peptides are well recognized as peptide isosters and powerful 
inhibitors of many classes of enzymes, mainly zinc proteases, Yiotakis et al. [81,82] reported the 
synthesis of phosphinopeptidic building blocks incorporating a triple bond, which through  
1,3-dipolar cycloaddition process, gives access to novel class of isoxazole-containing phosphinic 
peptides. Thus, the reaction of N-Cbz H-phosphinic acid analogue of phenylalanine (R)-66a [72] with 
TMSCl/DIPEA followed by the addition of ethyl α-propargylic acrylate and saponification of the 
ethyl ester, gave the C-phosphinates 87 in 96% yield and 3.5:1 diastereoisomeric ratio. Coupling of 87 
with (S)-TrpNH2 afforded the tripeptide 88 as a diastereoisomeric mixture, from which the 
diastereoisomer (R,S,S)-88 was isolated by means of simple crystallization. Finally, the 1,3-dipolar 
cycloaddition reaction of (R,S,S)-88 with different nitrile oxides generated in situ from the chlorination of 
the corresponding oxime, furnished the isoxazoles (R,S,S)-89a–d in good yields (Scheme 37). 
On the other hand, the 1,3-dipolar cycloaddition reaction of propargylic C-phosphinic acid 87 
(1:1 diastereoisomeric mixture) [81] with benzonitrile oxide, gave the isoxazole-phosphinate 90 in 
83% yield, which by coupling with di-tert-butyl protected (S)-tyrosine followed by the cleavage of 
the tert-butyl group and semipreparative RP-HPLC isolation, provided the pure diastereoisomeric 
phosphinic tripeptide (R,R,S)-91 in 90% yield (Scheme 38) [83]. These compounds were administered 
intravenously and lowered mean arterial blood pressure in spontaneously hypertensive rats. 
In a similar way, Stratikos et al. [84] reported the synthesis of the phosphinic tripeptide  
(R,S,S)-94, which was tested in the inhibition of the endoplasmic reticulum aminopeptidases 1 and  
2 (ERAP1 and ERAP2), involved in regulation of cytotoxic cellular responses. Thus, the reaction of 
N-Boc H-phosphinic acid analogue of homophenylalanine (R)-92 [72] with HMDS followed by the 
addition of ethyl isobutylacrylate and saponification of the ethyl ester, gave the C-phosphinate 93 in 
72% yield, which by coupling with (S)-TrpNH2, deprotection and HPLC separation, afforded the 
phosphinic tripeptide (R,S,S)-94 in 87% (Scheme 39) [78]. 
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Similarly, the phosphinic pseudotripeptides (S,S,S)-85 and (S,R,S)-86 were obtained from the
enantiomeric pure N-Cbz H-phosphinic acid analogue of phenylalanine (S)-66a in 64% yield. As in the
previous example, each diastereoisomer showed different solubility properties in ethyl ether allowing
their complete separation (Scheme 36) [78].
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Considering that phosphinic peptides are well recognized as peptide isosters and powerful
inhibitors of many classes of enzymes, mainly zinc proteases, Yiotakis et al. [81,82] reported the
synthesis of phosphinopeptidic building blocks incorporating a triple bond, which through 1,3-dipolar
cycloaddition process, gives access to novel class of isoxazole-containing phosphinic peptides. Thus,
the reaction of N-Cbz H-phosphinic acid analogue of phenylalanine (R)-66a [72] with TMSCl/DIPEA
followed by the addition of ethyl α-propargylic acrylate and saponification of the ethyl ester, gave the
C-phosphinates 87 in 96% yield and 3.5:1 diastereoisomeric ratio. Coupling of 87 with (S)-TrpNH2
afforded the tripeptide 88 as a diastereoisomeric mixture, from which the diastereoisomer (R,S,S)-88
was isolated by means of simple crystallization. Finally, the 1,3-dipolar cycloaddition reaction of
(R,S,S)-88 with different nitrile oxides generated in situ from the chlorination of the corresponding
oxime, furnished the isoxazoles (R,S,S)-89a–d in good yields (Scheme 37).
On the other hand, the 1,3-dipolar cycloaddition reaction of propargylic C-phosphinic acid 87
(1:1 diastereoisomeric mixture) [81] with benzonitrile oxide, gave the isoxazole-phosphinate 90 in
83% yield, which by coupling with di-tert-butyl protected (S)-tyrosine followed by the cleavage of
the tert-butyl group and semipreparative RP-HPLC isolation, provided the pure diastereoisomeric
phosphinic tripeptide (R,R,S)-91 in 90% yield (Scheme 38) [83]. These compounds were administered
intravenously and lowered mean arterial blood pressure in spontaneously hypertensive rats.
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In a similar way, Stratikos et al. [84] reported the synthesis of the phosphinic tripeptide (R,S,S)-94,
which was tested in the inhibition of the endoplasmic reticulum aminopeptidases 1 and 2 (ERAP1
and ERAP2), involved in regulation of cytotoxic cellular responses. Thus, the reaction of N-Boc
H-phosphinic acid analogue of homophenylalanine (R)-92 [72] with HMDS followed by the addition
of ethyl isobutylacrylate and saponification of the ethyl ester, gave the C-phosphinate 93 in 72% yield,
which by coupling with (S)-TrpNH2, deprotection and HPLC separation, afforded the phosphinic
tripeptide (R,S,S)-94 in 87% (Scheme 39) [78].
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In order to functionalize the phosphinic pseudopeptide framework, Yiotakis et al. [85] developed
a simple and efficient method for P1′ diversification obtaining a variety of dehydrophosphinic peptides.
According to this strategy, the treatment of N-Cbz phenylalanine H-phosphinic analogue (S)-66a [72]
with TMSCl/DIPEA followed by addition of diethyl 2-methylenemalonate and subsequent alkaline
hydrolysis, afforded the phosphinic pseudodipeptide (S)-95 in 67% yield, which was subjected to a
Knoevenagel-type condensation with several aldehydes, to give the dehydrophosphinic peptides 96a–i
in good yields (Scheme 40).Molecules 2016, 21, 1141 20 of 29 
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Sche e 40. Synthesis of the dehydrophosphinic peptides 96a–i.
Gegnas et al. [86] described the synthesis of the phosphinic pseudopeptide 99, which proved to
be an inhibitor of the D-glutamic acid-adding enzyme (MurD) of bacterial peptidoglycan biosynthesis.
The nucleophilic addition of compound (R)-97 [72] to 2-methylene pentanedioate in the presence of
sodium methoxide provided the dipeptide isostere as a mixture of four diastereoisomers, which under
hydrogenolysis over Pd/C catalyst in methanol provided the derivative 98 with the free amino group
in 56% yield. Compound 98 was further transformed into the target pseudopeptide 99 in 2% overall
yield through a six steps sequence, whose biological activity lied below the sensitivity of the enzyme
assay used (<1 nM) (Scheme 41).
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c e e 41. Synthesis of the phosphinic pseudopeptide 99 and its activity as inhibitor of the D-glutamic
acid-adding enzyme (MurD) isolated from E. coli.
Additionally, Yiotakis et al. [87] developed an Ireland-Cl isen rearrangement triggered by
the phospha-Micha l addition of ilyl phosphonit to allyl acrylates, as a new strategy to ac ess
arm cologically releva t C-phosphinic derivatives. In is context, the reaction of Cbz-protected
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phenylalanine H-phosphinic analogue (R)-66a [72] with the acrylate in the presence of DIPEA in
CH2Cl2 followed by addition of TMSCl at −78 ◦C, provided the P-alkylated α-amino-C-phosphinic
acid (R)-100 in 52% yield with retention of configuration at phosphorus atom (Scheme 42).
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On the other hand, the diastereoselective synthesis of Pro-Phe phosphinyl dipeptide isosteres was
accomplished from optically active prolinephosphinate derivative (R,RP)-101 [88], which was obtained
in 13 steps from 1,1-diethoxyethyl(hydroxymethyl)phosphinate via a lipase-catalyzed acylation [89].
Thus, the Michael addition of the H-phosphinate (R,RP)-101 to t-butyl acrylate in the presence of
t-BuOMgBr in THF at 0 ◦C, provided the C-phosphinate (R,RP)-102 in 95% yield, which by treatment
with LiHMDS followed by the addition of benzyl bromide in THF at −78 ◦C, produced the Pro-Phe
phosphinyl dipeptide (R,RP,R)-103 in 81% yield and 4.8:1 diastereoisomeric ratio (Scheme 43).
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3. Synthesis of Phosphacyclic α-Amino-C-phosphinates
Several strategies for the preparation of P-heterocycles have been described over the last years,
and excellent reviews have been published [90–93]. In the past 20 years, significant effort has been
devoted to synthetic and reactivity studies of this particular class of compounds, here we only report
the stereoselective methods recently reported in the literature where the α-amino-C-phosphinate motif
is incorporated.
3.1. 1,4,2-Oxazaphosphacycles
The strategies described for the stereoselective synthesis of 1,4,2-oxazaphosphacycles typically
involve the diastereoselective nucleophilic addition-cyclization reaction fro hypophosphorous acid
( 3PO2) or ethyl hypophosphite ( 2PO2Me) and chiral imino alcohols (Scheme 44).
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With previously acquired knowledge in the preparation and reactivity of oxazaphosphinanes,
Pirat et al. [94] addressed the enantioselective synthesis of phosphinic analogues of 2-aryl-morpholinols,
which have shown strong activity on the noradrenergic systems [95] and therefore constitute new
Molecules 2016, 21, 1141 23 of 31
therapeutic means for depression treatment. Thus, the palladium catalyzed coupling of (2R,3R,5R)-104
with aryl halides and catalytic amounts of tetrakis(triphenylphosphine) palladium and Et3N in PhMe
at reflux, afforded the 2-aryl-1,4,2-oxazaphosphinanes (2R,3R,5R)-105a–e in 68%–74% yield as single
diastereoisomers (Scheme 45). The retention of configuration at phosphorus atom was confirmed
through X-ray analysis of final products.
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Treatment of (2R,3R,5R)-105a with 12 M HCl at 70 ◦C and subsequent addition of propylene
oxide, produced the (2S,3R,5R)-2,3,5-triphenyl-1,4,2-oxazaphosphinane (−)-106a in 80% yield through
a selective inversion of configuration at phosphorus center (Scheme 46) [94].
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3.2. 1,2-Oxaphosphacycles 
The stereoselective synthesis of 1,2-oxaphosphacycles with an exocyclic amino group has been 
performed, mainly through two pathways: (a) diastereoselective nucleophilic addition-cyclization 
reaction from arylphosphinates and chiral cyclic hemiaminals; or (b) substitution with  
N-nucleophiles on derivatized chiral 3-hydroxy-1,2-oxaphosphinanes (Scheme 49). 
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In a complementary work, Pirat et al. [96] evaluated the diastereoselectivity in the Michael
addition of the enantiomerically pure oxazaphosphinane (2S,3S,5S,6R)-107 to methyl cinnamate. Thus,
reaction of (2S,3S,5S,6R)-107 with catalytic amounts of potassium tert-butoxide in CH2Cl2 at room
temperature followed by the addition of methyl cinnamate, gave the cyclic α-amino-C-phosphinate
(2S,3S,5S,6R)-108 in 92% yield and with 70% diastereoisomeric excess (Scheme 47).
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3.2. 1,2-Oxaphosphacycles
The stereoselective synthesis of 1,2-oxaphosphacycles with an exocyclic amino group has been
performed, mainly through two pathways: (a) diastereoselective nucleophilic addition-cyclization
reaction from arylphosphinates and chiral cyclic hemiaminals; or (b) substitution with N-nucleophiles
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Finally, Bakalara et al. [99] carried out the synthesis of 3-amino-1,2-oxaphosphinanes as  
C-glycoside mimetics and new pharmacological agents against glioma stem cell proliferation, 
migration and invasion. In this respect, the condensation of the 2,3,5,6-di-O-isopropylidene-α-D-
manno-furanose (3S,4S,5R)-119 with different amines in the presence of MgSO4 in EtOH at reflux, 
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ethyl phenylphosphinate and cyclization in the presence of catalytic amounts of potassium  
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For example, the reaction of tris(benzyloxy)-D-arabinofuranose 113 with ethyl phenylphosphinate
in the presence of catalytic amounts of potassium tert-butoxide followed by preparative reverse
phase HPLC separation, led to the cyclic α-amino-C-phosphinate (2S,3R,4S,5S,6R)-114 in 17% yield.
The reaction of (2S,3R,4S,5S,6R)-114 with triflic anhydride in the presence of pyridine in CH2Cl2 at 0 ◦C,
produced the triflate, which without additional purification it was reacted with trimethylsilylazide in
the presence of TBAF in THF at 65 ◦C, obtaining the azido derivative (2S,3S,4S,5S,6R)-115 in 28% yield.
Finally, reduction of azide group in the compound 115 with Ph3P/THF/H2O, furnished the glucose
like oxaphosphinane (2S,3S,4S,5S,6R)-116 in 42% yield, which was tested for their antiproliferative
activity in the search for new therapeutic agents against glioblastoma (Scheme 50) [98].
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of catalytic amounts of potassium tert-butoxide, afforded the 3-alkylamino-1,2-oxaphosphinanes 118a,b
in 12% and 7% yield, respectively (Scheme 51) [98].
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Finally, Bakalara et al. [99] carried out the synthesis of 3-amino-1,2-oxaphosphinanes as
C-glycoside mimetics and new pharmacological agents against glioma stem cell proliferation, migration
and invasion. In this respect, the condensation of the 2,3,5,6-di-O-isopropylidene-α-D-manno-furanose
(3S,4S,5R)-119 with different amines in the presence of MgSO4 in EtOH at reflux, afforded the
cyclic hemiaminal ethers (3S,4S,5R)-120a–d in 58%–90% yield, which by reaction with ethyl
phenylphosphinate and cyclization in the presence of catalytic amounts of potassium tert-butoxide,
produced the 3-aryl or 3-alkylamino-1,2-oxaphosphinanes (2S,3S,4S,5R,6R)-121a–d in 53%–73% yield
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4. Conclusions 
In this review, we have covered recent progress in the development of stereoselective 
methodologies for the synthesis of both acyclic and cyclic α-amino-C-phosphinic acids and 
derivatives. As we have shown, a number of optically active α-amino-C-phosphinic derivatives are 
now accessible through different strategies; however, there is still a long way to be covered, 
considering the poor availability of stereoselective methods for the preparation of pure stereoisomers 
of phosphinic peptides, taking into account that diastereoisomers with a particular three dimensional 
structure are able to interact efficiently with the receptor binding site, while other configurations are 
discriminated. Authors believe that much effort must be made in this direction and further advances 
in the search and improvement of synthetic procedures, new chemical applications and biological 
activities of these interesting compounds will be a very rewarding task in coming years. 
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4. Conclusions
In this review, we have covered recent progress in the development of stereoselective
methodologies for the synthesis of both acyclic and cyclic α-amino-C-phosphinic acids and derivatives.
As we have shown, a number of optically active α-amino-C-phosphinic derivatives are now accessible
through different strategies; however, there is still a long way to be covered, considering the poor
availability of stereoselective methods for the preparation of pure stereoisomers of phosphinic peptides,
taking into account that diastereoisomers with a particular three dimensional structure are able to
interact efficiently with the receptor binding site, while other configurations are discriminated. Authors
believe that much effort must be made in this direction and further advances in the search and
improvement of synthetic procedures, new chemical applications and biological activities of these
interesting compounds will be a very rewarding task in coming years.
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